Review decisions
Showing 850 results of 1549 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00669
Product Type: Drug
Control Number: 240551
DIN(s): 02502135, 02502143
Manufacturer: Gilead Sciences Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2020-06-19
Decision / Authorization Date: 2020-07-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00678
Product Type: Drug
Control Number: 230407
Manufacturer: Octapharma Pharmazeutika Produktionsges m.b.H.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-08-06
Decision / Authorization Date: 2020-07-16
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00694
Product Type: Drug
Control Number: 231245
DIN(s): 02498650
Manufacturer: Sterimax Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2019-08-30
Decision / Authorization Date: 2020-07-15
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00767
Product Type: Drug
Control Number: 233292
DIN(s): 02501821, 02501848
Manufacturer: Sunovion Pharmaceuticals Canada Inc.
Submission Type: New Drug Submission (New Active Substance) - Priority Review
Date Filed / Submission Date: 2019-11-07
Decision / Authorization Date: 2020-07-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00713
Product Type: Drug
Control Number: 232303
DIN(s): 02499614
Manufacturer: Hoffmann-La Roche Ltd.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2019-10-07
Decision / Authorization Date: 2020-07-09
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00787
Product Type: Drug
Control Number: 230147
DIN(s): 02501813
Manufacturer: Fresenius Kabi Canada Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-07-30
Decision / Authorization Date: 2020-07-09
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00794
Product Type: Drug
Control Number: 230307
DIN(s): 02501775
Manufacturer: Fresenius Kabi Canada Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-08-01
Decision / Authorization Date: 2020-07-09
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00693
Product Type: Drug
Control Number: 228353
DIN(s): 02501244
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2019-07-22
Decision / Authorization Date: 2020-07-02
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00687
Product Type: Drug
Control Number: 226954
Manufacturer: EMD Serono, A Division of EMD Inc., Canada
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-04-18
Decision / Authorization Date: 2020-06-30
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00682
Product Type: Drug
Control Number: 234304
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission - Priority Review
Date Filed / Submission Date: 2019-12-10
Decision / Authorization Date: 2020-06-30